Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial
Crossref DOI link: https://doi.org/10.1007/s10147-014-0697-z
Published Online: 2014-05-20
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shimoyama, Naohito
Gomyo, Ikuo
Katakami, Nobuyuki
Okada, Masakuni
Yukitoshi, Nobuyuki
Ohta, Eri
Shimoyama, Megumi
Text and Data Mining valid from 2014-05-20